Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

Sabita S. Soedamah-Muthu, Shona J. Livingstone, Valentine Charlton-Menys, D. John Betteridge, Graham A. Hitman, H. Andrew W. Neil, Weihang Bao, David A. DeMicco, Gregory M. Preston, John H. Fuller, Coen D. A. Stehouwer, Casper G. Schalkwijk, Paul N. Durrington, Helen M. Colhoun

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1494-1502
JournalDiabetologia
Volume58
Issue number7
DOIs
Publication statusPublished - Jul 2015

Keywords

  • Atorvastatin
  • Cardiovascular disease
  • CARDS
  • C-reactiveprotein
  • LDL-cholesterol
  • Statins
  • Type 2 diabetes

Cite this